Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
 — 
See All Episodes
Subscribe

Hey, LA listener!

Download our app for the optimal streaming experience

Apple Store logo Google play logo
  • Listen Now Playing Listen
  • Listen Now Playing Listen
AirTalk

COVID-19 AMA: Pfizer & BioNTech Apply For Full FDA Approval, WHO Considers Emergency Use Of Chinese Vaccine And More

By AirTalk Staff
Published May 7, 2021
WASHINGTON, DC - MAY 06: DC Health Nurse Manager Ashley Hennigan fills a syringe with a dose of the Johnson & Johnson coronavirus vaccine during a walk-up clinic at the John F. Kennedy Center for the Performing Arts' outdoor Reach area on May 06, 2021 in Washington, DC. Hosted by the District of Columbia Health Department, the event also provided newly vaccinated people with a free beer courtesy of Solace Brewing Co. (Photo by Chip Somodevilla/Getty Images)
DC Health Nurse Manager Ashley Hennigan fills a syringe with a dose of the Johnson & Johnson coronavirus vaccine during a walk-up clinic at the John F. Kennedy Center for the Performing Arts' outdoor Reach area on May 06, 2021 in Washington, DC.
(
Chip Somodevilla/Getty Images
)
Listen 20:41
COVID-19 AMA: Pfizer & BioNTech Apply For Full FDA Approval, WHO Considers Emergency Use Of Chinese Vaccine And More

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Dr. Dean Blumberg from UC Davis Children’s Hospital.  

Topics today include:

  • There might be a shortage of special syringes, leading to vaccine waste

  • WHO considers EUA of Chinese vaccine 

  • Pfizer and BioNTech apply for full FDA approval 

  • Poll: socializing maskless might not incentive unvaccinated people 

  • Is vaccine approval for 12-15 year olds imminent? 

Guest:

Dean Blumberg, M.D., professor of medicine and chief of Pediatric Infectious Diseases at UC Davis Children’s Hospital; he tweets